These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 38194422

  • 1. PIK3CA regulates development of diabetes retinopathy through the PI3K/Akt/mTOR pathway.
    Guan R, Kang Z, Li L, Yan X, Gao T.
    PLoS One; 2024; 19(1):e0295813. PubMed ID: 38194422
    [Abstract] [Full Text] [Related]

  • 2. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of cc chemokine receptor 10 ameliorates osteoarthritis via inhibition of the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin pathway.
    Luo Y, Zhou F, Wang X, Yang R, Li Y, Wu X, Ye B.
    J Orthop Surg Res; 2024 Mar 01; 19(1):158. PubMed ID: 38429844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway.
    Chen Z, Wang C, Dong H, Wang X, Gao F, Zhang S, Zhang X.
    Mol Med; 2020 Jan 30; 26(1):14. PubMed ID: 32000660
    [Abstract] [Full Text] [Related]

  • 8. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM, Zhang ZZ, Ma X, Fang SF, Qin XH.
    Exp Eye Res; 2020 Jan 30; 190():107886. PubMed ID: 31759996
    [Abstract] [Full Text] [Related]

  • 9. Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel-Trenaunay syndrome in an Asian population : List the full names and institutional addresses for all authors.
    Sasaki Y, Ishikawa K, Hatanaka KC, Oyamada Y, Sakuhara Y, Shimizu T, Saito T, Murao N, Onodera T, Miura T, Maeda T, Funayama E, Hatanaka Y, Yamamoto Y, Sasaki S.
    Orphanet J Rare Dis; 2023 Sep 04; 18(1):270. PubMed ID: 37667289
    [Abstract] [Full Text] [Related]

  • 10. Single-cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation.
    Xu L, Ding R, Song S, Liu J, Li J, Ju X, Ju B.
    J Gene Med; 2024 Jan 04; 26(1):e3658. PubMed ID: 38282149
    [Abstract] [Full Text] [Related]

  • 11. [Acupuncture regulates PI3K/Akt/mTOR signaling and up-regulates cell autophagy to protect sy-novial tissue of adjuvant arthritis rats].
    Zhao C, Zhang M, Zhu Y, Jiang L, Hong MY, Zhang YL, Wang WY, Yu HW.
    Zhen Ci Yan Jiu; 2021 Dec 25; 46(12):1016-22. PubMed ID: 34970878
    [Abstract] [Full Text] [Related]

  • 12. The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS).
    Suzuki Y, Enokido Y, Yamada K, Inaba M, Kuwata K, Hanada N, Morishita T, Mizuno S, Wakamatsu N.
    Oncotarget; 2017 Jul 11; 8(28):45470-45483. PubMed ID: 28525374
    [Abstract] [Full Text] [Related]

  • 13. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
    Ippen FM, Grosch JK, Subramanian M, Kuter BM, Liederer BM, Plise EG, Mora JL, Nayyar N, Schmidt SP, Giobbie-Hurder A, Martinez-Lage M, Carter SL, Cahill DP, Wakimoto H, Brastianos PK.
    Neuro Oncol; 2019 Nov 04; 21(11):1401-1411. PubMed ID: 31173106
    [Abstract] [Full Text] [Related]

  • 14. PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
    Beelen K, Opdam M, Severson TM, Koornstra RH, Vincent AD, Wesseling J, Muris JJ, Berns EM, Vermorken JB, van Diest PJ, Linn SC.
    Breast Cancer Res; 2014 Jan 27; 16(1):R13. PubMed ID: 24467828
    [Abstract] [Full Text] [Related]

  • 15. Protective Effects of MicroRNA-126 on Human Cardiac Microvascular Endothelial Cells Against Hypoxia/Reoxygenation-Induced Injury and Inflammatory Response by Activating PI3K/Akt/eNOS Signaling Pathway.
    Yang HH, Chen Y, Gao CY, Cui ZT, Yao JM.
    Cell Physiol Biochem; 2017 Jan 27; 42(2):506-518. PubMed ID: 28578351
    [Abstract] [Full Text] [Related]

  • 16. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S, Zhang Y, Huang C, Lin S.
    J Cell Biochem; 2020 Feb 27; 121(2):1475-1490. PubMed ID: 31498483
    [Abstract] [Full Text] [Related]

  • 17. Effect of moxibustion on autophagy and the inflammatory response of synovial cells in rheumatoid arthritis model rat.
    Hao F, Wang Q, Liu L, Wu LB, Cai RL, Sang JJ, Hu J, Wang J, Yu Q, He L, Shen YC, Miao YM, Hu L, Wu ZJ.
    J Tradit Chin Med; 2022 Feb 27; 42(1):73-82. PubMed ID: 35294125
    [Abstract] [Full Text] [Related]

  • 18. In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).
    Ranieri C, Di Tommaso S, Loconte DC, Grossi V, Sanese P, Bagnulo R, Susca FC, Forte G, Peserico A, De Luisi A, Bartuli A, Selicorni A, Melis D, Lerone M, Praticò AD, Abbadessa G, Yu Y, Schwartz B, Ruggieri M, Simone C, Resta N.
    Neurogenetics; 2018 May 27; 19(2):77-91. PubMed ID: 29549527
    [Abstract] [Full Text] [Related]

  • 19. The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating study.
    Huang L, Yang H, Chen K, Yuan J, Li J, Dai G, Gu M, Shi Y.
    Clin Transl Med; 2023 Dec 27; 13(12):e1500. PubMed ID: 38037549
    [Abstract] [Full Text] [Related]

  • 20. PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
    Janku F, Wheler JJ, Westin SN, Moulder SL, Naing A, Tsimberidou AM, Fu S, Falchook GS, Hong DS, Garrido-Laguna I, Luthra R, Lee JJ, Lu KH, Kurzrock R.
    J Clin Oncol; 2012 Mar 10; 30(8):777-82. PubMed ID: 22271473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.